The price of Humalog 200 KwikPen can vary depending on factors such as pharmacy, insurance coverage, and dosage. A single KwikPen, which contains 200 units of insulin lispro, is often sold in packs of five.
What is the typical cost of Humalog 200 KwikPen without insurance?
Without insurance, the retail price for a 5-pack of Humalog 200 KwikPens can range from approximately $700 to over $900 [1]. This price can fluctuate based on the specific pharmacy and location.
How can I get a discount on Humalog 200 KwikPen?
For those with commercial prescription insurance, Eli Lilly and Company, the manufacturer of Humalog, offers a savings card that can significantly reduce out-of-pocket costs. This program could potentially lower the monthly cost for eligible patients to as little as $35 [1]. Eligibility requirements apply.
What is the difference between Humalog KwikPen and Humalog Junior KwikPen?
The Humalog KwikPen delivers 100 units of insulin lispro per milliliter (U-100), while the Humalog Junior KwikPen delivers 200 units of insulin lispro per milliliter (U-200) [2]. The U-200 pen is designed to deliver a higher concentration of insulin in a smaller volume, allowing for larger doses to be administered with fewer clicks.
When does the patent for Humalog expire?
The patents for Humalog have expired [3]. This means that other companies can develop and market generic versions of insulin lispro.
Are there generic alternatives to Humalog?
Yes, generic versions of insulin lispro are available. These generics are bioequivalent to Humalog and are often offered at a lower price point.
Where can I compare prices for Humalog 200 KwikPen?
DrugPatentWatch.com provides information on drug patents and can be a resource for understanding the patent landscape of medications like Humalog [3]. For current pricing comparisons, consulting with local pharmacies or using online pharmacy price comparison tools is recommended.
Sources:
[1] https://www.humalog.com/savings-and-support
[2] https://www.humalog.com/insulin-types/kwikpen-insulin-pens
[3] https://drugpatentwatch.com/